Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Lacouture

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Pediatric Hematology/Oncology|August 23, 2024
Omalizumab for Treatment of Anti-GD2 Antibody-related UrticariaRachel Glincher, Angela Lentini-Rivera, Latisha Andre Jones, et al.
Research Square|May 10, 2023
Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer PatientsStephanie Gu, Stephen Dusza, Elizabeth Quigley, et al.
Frontiers in Oncology|January 27, 2023
Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic regionMilan J Anadkat, Mario Lacouture, Adam Friedman, et al.
Journal of the American Academy of Dermatology|July 1, 2026
Sparse Insurance and Alopecia Information Availability Among New York City Wig Providers: A Cross-Sectional StudyArchie Spindler, Derek Maas, Maanasa Pulavarty, et al.
Journal of the American Academy of Dermatology|November 28, 2025
No serum estradiol changes with 5-alpha reductase inhibitors for late alopecia in cancer survivors: A retrospective cohort studyMichael M Ong, Lavanya Mittal, Mario Lacouture, et al.
Journal of Drugs in Dermatology : JDD|July 6, 2026
Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology PatientsDaniel Alcalá Pérez, Anneke Andriessen, Vanja Adzovic, et al.
Journal of the American Academy of Dermatology|October 5, 2015
Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC)Andrea Luísa Suárez, Peter Louis, Jasmine Kitts, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2023
The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensusBrigitte Dreno, Kiarash Khosrotehrani, Giselle De Barros Silva, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2025
Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and SurvivorsDaniel Alcalá Pérez, Ana Sofia Acosta Madiedo, Sebastian Andreani, et al.
Cancer Medicine|April 5, 2023
A five arm natural history study of nasal vestibulitisElizabeth J Cathcart-Rake, David Zahrieh, Deanne Smith, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Pediatric Hematology/Oncology|August 23, 2024
Omalizumab for Treatment of Anti-GD2 Antibody-related UrticariaRachel Glincher, Angela Lentini-Rivera, Latisha Andre Jones, et al.
Research Square|May 10, 2023
Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer PatientsStephanie Gu, Stephen Dusza, Elizabeth Quigley, et al.
Frontiers in Oncology|January 27, 2023
Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic regionMilan J Anadkat, Mario Lacouture, Adam Friedman, et al.
Journal of the American Academy of Dermatology|July 1, 2026
Sparse Insurance and Alopecia Information Availability Among New York City Wig Providers: A Cross-Sectional StudyArchie Spindler, Derek Maas, Maanasa Pulavarty, et al.
Journal of the American Academy of Dermatology|November 28, 2025
No serum estradiol changes with 5-alpha reductase inhibitors for late alopecia in cancer survivors: A retrospective cohort studyMichael M Ong, Lavanya Mittal, Mario Lacouture, et al.
Journal of Drugs in Dermatology : JDD|July 6, 2026
Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology PatientsDaniel Alcalá Pérez, Anneke Andriessen, Vanja Adzovic, et al.
Journal of the American Academy of Dermatology|October 5, 2015
Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC)Andrea Luísa Suárez, Peter Louis, Jasmine Kitts, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2023
The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensusBrigitte Dreno, Kiarash Khosrotehrani, Giselle De Barros Silva, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2025
Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and SurvivorsDaniel Alcalá Pérez, Ana Sofia Acosta Madiedo, Sebastian Andreani, et al.
Cancer Medicine|April 5, 2023
A five arm natural history study of nasal vestibulitisElizabeth J Cathcart-Rake, David Zahrieh, Deanne Smith, et al.
Pageof 6